Influence of therapeutic plasmapheresis on elimination of ceftiaxone
Authors:
- 1 May 1993
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (5) , 1171-1173
Abstract
To study the plasma elimination rate of ceftriaxone given to patients undergoing plasmapheresis, a single 2-g intravenous dose of ceftriaxone was given to 11 patients who underwent plasmapheresis 3 h (early group) or 15 h (late group) later. Even though the early patient group had twofold more ceftriaxone removed than the late group, all individual patients had 24-h ceftriaxone levels of 9 micrograms/ml or higher. We conclude that patients undergoing plasmapheresis lasting 150 min or less may safely be treated with 2 g of ceftriaxone once daily without risking periods of subtherapeutic plasma ceftriaxone levels.Keywords
This publication has 8 references indexed in Scilit:
- Purpura Fulminans and Symmetrical Peripheral Gangrene Caused by Capnocytophaga canimorsus (Formerly DF-2) Septicemia—A Complication of Dog BiteMedicine, 1991
- Successful therapy of meningococcal sepsis in acute disseminated lupus erythematosus with plasmapheresis, immunosuppression, and antibioticsJournal of Molecular Medicine, 1990
- Influence of plasma exchange pheresis on plasma elimination of ceftriaxoneAntimicrobial Agents and Chemotherapy, 1990
- Plasmapheresis and guillain‐barré syndrome: Analysis of prognostic factors and the effect of plasmapheresisAnnals of Neurology, 1988
- Kinetics of ceftazidime during plasmapheresisEuropean Journal of Clinical Pharmacology, 1987
- Kinetics of antimicrobial activityThe Journal of Pediatrics, 1986
- Pharmacokinetics of ceftriaxone in humansAntimicrobial Agents and Chemotherapy, 1981
- Postantibiotic Suppression of Bacterial GrowthClinical Infectious Diseases, 1981